Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
iTeos Therapeutics, Inc.
| Metric | iTeos Therapeutics, Inc. ITOSHealthcare |
|---|---|
| Quality Score | 73 / 100 |
| Revenue (latest) | $35M |
| Net income (latest) | −$134M |
| Operating margin | −455.8% |
| Net margin | −384.0% |
| Return on equity | −22.8% |
| Return on assets | −19.6% |
| Return on capital (ROCE) | −24.7% |
| Debt / equity | 0.16× |
| Revenue growth (YoY) | 177.9% |
| Altman Z″ (distress) | 9.28 |
| Accruals / assets | −5.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.